Search

Car-T Cell Therapy Sartorius Announces Third Research Xchange Forum

| Editor: Alexander Stark

The focus of Sartorius' third Research Xchange Forum (RXF2019) on April 25, 2019 will be on Car-T cell therapy. By organizing this event, the company intends to promote interdisciplinary exchange and foster potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses.

Sartorius is hosting its third Research Xchange Forum (RXF2019) on April 25, 2019, which will spotlight Car-T cell therapy.
Sartorius is hosting its third Research Xchange Forum (RXF2019) on April 25, 2019, which will spotlight Car-T cell therapy.
(Source: Sartorius )

Göttingen/Germany — The forum is organized in collaboration with Science/AAAS. The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and the forum will be held at the AAAS headquarters in Washington DC. Experts from the academic, clinical and biotech sectors will offer insights on novel developments in CAR-T cell therapies.

Guest speakers will include Prof. Bruce Levine (University of Pennsylvania), Rick Morgan, Sr. VP Immunogenetics (Editas Medicine), and others from institutions such as UCLA, Boston University, MD Anderson Cancer Center, Horizon Discovery, Colorado State University, Masthercell and St. Jude Children's Research Hospital.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy will be awarded in an invitation only post-event ceremony. Through sponsoring the award, Sartorius and Science/AAAS aim to recognize outstanding research contributions made in the regenerative medicine and cell therapy fields by the next generation of young scientists, the next thought leaders shaping our future as a society.

Visit the company's website to register free of charge for the RXF2019

This article is protected by copyright. You want to use it for your own purpose? Contact us at support.vogel.de (ID: 45795654)